Your browser doesn't support javascript.
loading
Effectiveness of Intermediate Cervical Plexus Block in Whiplash-Associated Disorder: A Prospective Observational Trial in Fifty Patients.
James, Arul; Lee, Hayun; Niraj, Shruti; Kukreja, Yuvraj; Mittal, Manish; Niraj, G.
Afiliación
  • James A; Clinical Research Unit in Pain Medicine, University Hospitals of Leicester NHS Trust.
  • Lee H; Clinical Research Unit in Pain Medicine, University Hospitals of Leicester NHS Trust.
  • Niraj S; Clinical Research Unit in Pain Medicine, University Hospitals of Leicester NHS Trust.
  • Kukreja Y; Clinical Research Unit in Pain Medicine, University Hospitals of Leicester NHS Trust.
  • Mittal M; Clinical Research Unit in Pain Medicine, University Hospitals of Leicester NHS Trust.
  • Niraj G; Clinical Research Unit in Pain Medicine, University Hospitals of Leicester NHS Trust.
Pain Physician ; 26(4): E375-E382, 2023 07.
Article en En | MEDLINE | ID: mdl-37535784
ABSTRACT

BACKGROUND:

Whiplash trauma can result in a range of symptoms, including chronic neck pain, headache, facial pain, upper back pain, and tinnitus, which comprises whiplash-associated disorder (WAD). Intermediate cervical plexus block (iCPB) is a novel intervention that targets the upper cervical nerves and anecdotal reports suggest benefits in WAD.

OBJECTIVES:

We hypothesized that the cervical plexus may have a role in the pathogenesis of WAD and blocking the cervical plexus may provide analgesia. STUDY

DESIGN:

Prospective observational trial.

SETTING:

Tertiary pain medicine unit at a university teaching hospital.

METHODS:

Adult patients who presented with refractory chronic neck pain following whiplash were included in a prospective observational trial. The pragmatic trial studied the effectiveness of 2 sequential cervical plexus blocks (iCPB with local anesthetic [iCPB-LA] and iCPB with steroid and LA mixture [iCPB-Steroid]) in refractory chronic neck pain following whiplash. Patients who reported < 50% relief at 12 weeks after iCPB-LA were offered iCPB-Steroid. Primary outcome was "neck pain at its worst in the last 24 hours" at 12 weeks. Secondary outcomes included change in neck disability index, employment status, and mood.

RESULTS:

After excluding cervical zygapophyseal joint dysfunction, 50 patients underwent the iCPB-LA between June 2020 and August 2022. Five patients reported > 50% relief (durable relief) at 12 weeks and 3 patients were lost to follow-up. Forty-two patients received iCPB-Steroid. iCPB-Steroid was associated with significant reduction in neck pain, neck disability, and improvement in mood at 12 weeks when compared to the block with LA. In addition, iCPB-Steroid was associated with significant reduction in neck pain and disability at 24 weeks. Due to functional improvement, 34 patients (34/50, 78%) were able to maintain employment.

LIMITATIONS:

This is an open-label, observational, single-center study in a limited cohort under a single physician. Cervical facet joint dysfunction was ruled out clinically and radiologically.

CONCLUSIONS:

Cervical plexus may play a central role in the pathogenesis of WAD. iCPB could potentially be a treatment option in this cohort.
Asunto(s)
Palabras clave
Buscar en Google
Base de datos: MEDLINE Asunto principal: Lesiones por Latigazo Cervical / Dolor Crónico / Bloqueo del Plexo Cervical Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Idioma: En Revista: Pain Physician Asunto de la revista: PSICOFISIOLOGIA Año: 2023 Tipo del documento: Article
Buscar en Google
Base de datos: MEDLINE Asunto principal: Lesiones por Latigazo Cervical / Dolor Crónico / Bloqueo del Plexo Cervical Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Idioma: En Revista: Pain Physician Asunto de la revista: PSICOFISIOLOGIA Año: 2023 Tipo del documento: Article